Literature DB >> 303498

Side effects of minocycline: different dosage regimens.

D W Gump, T Ashikaga, T J Fink, A M Radin.   

Abstract

The incidence of side effects due to two dosage regimens of minocycline was examined over a 5-day period. A total of 60 normal women volunteers were randomly assigned in a double-blind manner to either a group who took 100 mg of minocycline twice a day or a group who took 75 mg of minocycline twice a day for 5 days. Both groups were comparable from the standpoints of age, size, race, and the use of oral contraception, nicotine, and ethanol. They were seen on a daily basis, and symptoms were evaluated by both volunteers (from diaries) and physicians. Minocycline serum concentrations were determined on blood samples taken 2 h after the a.m. dose. Volunteers taking 150 mg of minocycline per day had significantly lower serum antibiotic concentrations than those taking 200 mg per day. However, both low- and high-dose groups exhibited similar incidence and prevalence of recorded symptoms, with the single exception of nausea, where the low-dose group had fewer symptoms than the high-dose group (P = 0.035). Symptomatic volunteers did not have higher serum concentrations of minocycline than their asymptomatic counterparts. When either weight or surface area was examined with antibiotic serum concentration there was a significant inverse correlation between the two on day 2 for both groups and also on day 4 for the low-dose group. It is concluded that, in women, a dose of 150 mg of minocycline per day is associated with the same degree of side effects as a dose of 200 mg per day.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303498      PMCID: PMC429991          DOI: 10.1128/AAC.12.5.642

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Pharmacokinetic studies on minocycline in man.

Authors:  H Macdonald; R G Kelly; E S Allen; J F Noble; L A Kanegis
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

2.  Clinical pharmacologic studies with minocycline.

Authors:  B Bernard; E J Yin; H J Simon
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Sep-Oct

3.  Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Side effects of minocycline: a double-blind study.

Authors:  W L Fanning; D W Gump; R A Sofferman
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

Review 5.  Minocycline.

Authors:  J C Allen
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391

  5 in total
  10 in total

Review 1.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus.

Authors:  J V Crues; B E Murray; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

Review 3.  Minocycline for acne vulgaris: efficacy and safety.

Authors:  Sarah E Garner; Anne Eady; Cathy Bennett; John Norman Newton; Karen Thomas; Catalin Mihai Popescu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives.

Authors:  James J Leyden; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-02

5.  Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury.

Authors:  Erzsebet Kovesdi; Alaa Kamnaksh; Daniel Wingo; Farid Ahmed; Neil E Grunberg; Joseph B Long; Christine E Kasper; Denes V Agoston
Journal:  Front Neurol       Date:  2012-07-16       Impact factor: 4.003

6.  Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

Authors:  Mary A Bitta; Symon M Kariuki; Clifford Mwita; Samson Gwer; Leah Mwai; Charles R J C Newton
Journal:  Wellcome Open Res       Date:  2017-06-02

7.  Minocycline-induced transient depersonalization: A case report.

Authors:  Yassein Shamout; Alissa Sigal; Ivan V Litvinov
Journal:  SAGE Open Med Case Rep       Date:  2019-01-17

8.  Minocycline Alleviates Cluster Formation of Activated Microglia and Age-dependent Dopaminergic Cell Death in the Substantia Nigra of Zitter Mutant Rat.

Authors:  Daisuke Taguchi; Ayuka Ehara; Taro Kadowaki; Shin-Ichi Sakakibara; Kazuhiko Nakadate; Koichi Hirata; Shuichi Ueda
Journal:  Acta Histochem Cytochem       Date:  2020-11-21       Impact factor: 1.938

9.  Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease.

Authors:  Katharina Faust; Stephan Gehrke; Yufeng Yang; Lichuan Yang; M Flint Beal; Bingwei Lu
Journal:  BMC Neurosci       Date:  2009-09-01       Impact factor: 3.288

Review 10.  A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea.

Authors:  Ana M Martins; Joana M Marto; Jodi L Johnson; Emmy M Graber
Journal:  Antibiotics (Basel)       Date:  2021-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.